申请人:Skyhawk Therapeutics, Inc.
公开号:US20220048902A1
公开(公告)日:2022-02-17
Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, pharmaceutical compositions comprising the same, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.